Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

May 31, 2025

Conditions
Hypertension AssociatedType II Diabetes Mellitus
Interventions
DRUG

Egito

EGITO Egito coated tablet. EMPAGLIFLOZIN PLACEBO Empagliflozin placebo coated tablet. TELMISARTAN PLACEBO Telmisartan coated tablet.

DRUG

Empagliflozin + telmisartan

Drug: EMPAGLIFLOZIN Empagliflozin 25 mg coated tablet. Drug: TELMISARTAN Telmisartan 40/80 mg coated tablet. EGITO PLACEBO Egito placebo coated tablet.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EMS

INDUSTRY